Mona Kay Rifi
About Mona Kay Rifi
Mona Kay Rifi is the Director of Compliance Training & Communication at Bristol Myers Squibb, with extensive experience in healthcare compliance and training.
Title
Mona Kay Rifi currently holds the title of Director Of Compliance Training & Communication at Bristol Myers Squibb.
Current Role at Bristol Myers Squibb
Mona Kay Rifi is the Director of Compliance Training & Communication at Bristol Myers Squibb. In this role, she has developed and implemented compliance training programs that align with industry laws and regulations. She is known for creating an environment that encourages employees to 'speak up' and ask questions regarding compliance issues.
Previous Experience
Before joining Bristol Myers Squibb, Mona Kay Rifi served as a Principal at Innovate Compliance in the New York City Metropolitan Area for five months in 2020. She also worked at Valeritas as Director of Training & Compliance Liaison from 2016 to 2020. Her extensive background includes roles at Novo Nordisk, where she held various positions from 2010 to 2016, including Compliance Business Partner & Training Manager. Additionally, she has extensive experience in sales and training roles at Sanofi Aventis U.S. and DuPont Pharmaceuticals.
Education and Training
Mona Kay Rifi studied at the University of Delaware, where she achieved a Bachelor of Science in Medical Technology, graduating in 1987. Her education has laid a strong foundation for her extensive career in healthcare compliance and training.
Skills and Expertise
Mona Kay Rifi is skilled in delivering training that integrates business objectives with compliance requirements. She has expertise in operationalizing policies and SOPs to ensure compliance and is adept at performing risk assessments. She also has a strong background in healthcare compliance, including knowledge of the Anti-Kickback Statute, False Claims Act, and FCPA. Proficient in using compliance-related software such as Veeva, Concur, and ComplianceWire, Mona is also well-versed in FDA regulations and Corporate Integrity Agreements.